Ogata N, Ohishi Y (2002) Molecular diversity of structure and function of the voltage-gated Na+

channels. Jpn J Pharmacol 88(4):365–377

Oyibo SO, Prasad YDM, Jackson NJ, Jude EB, Boulton AJM (2002) The relationship between

blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med

19(10):870–873

Ozpolat B, Sood AK, Lopez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy.

Adv Drug Deliv Rev 66:110–116

Quattrini C, Tesfaye S (2003) Understanding the impact of painful diabetic neuropathy. Diabetes

Metab Res Rev 19:S2–S8

Roy ML, Narahashi T (1992) Differential properties of tetrodotoxin-sensitive and tetrodotoxin-

resistant sodium channels in rat dorsal root ganglion neurons. J Neurosci 12(6):2104–2111

Schreiber AK (2015) Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes

6(3):432

Serrano-Sevilla I, Artiga Á, Mitchell SG, De Matteis L, de la Fuente JM (2019) Natural

polysaccharides for siRNA delivery: nanocarriers based on chitosan, hyaluronic acid, and

their derivatives. Molecules 24:2570

Setten RL, Rossi JJ, Ping HS (2019) The current state and future directions of RNAi-based

therapeutics. Nat Rev Drug Discov 18(6):421–446

Shende P, Patel C (2019) siRNA: an alternative treatment for diabetes and associated conditions. J

Drug Target 27:174–182

Shishkin V, Potapenko E, Kostyuk E, Girnyk O, Voitenko N, Kostyuk P (2002) Role of

mitochondria in intracellular calcium signaling in primary and secondary sensory neurones of

rats. Cell Calcium 32(3):121–130

Siau C, Xiao W, Bennett G (2006) Paclitaxel- and vincristine-evoked painful peripheral

neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol

201(2):507–514. https://linkinghub.elsevier.com/retrieve/pii/S0014488606002937

Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ et al (2017) Capsaicin 8%

patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled

study. J Pain 18(1):42–53

Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance

in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453

Stino AM, Smith AG (2017) Peripheral neuropathy in prediabetes and the metabolic syndrome. J

Diabetes Investig 8(5):646–655

Subhan MA, Torchilin VP (2019) Efficient nanocarriers of siRNA therapeutics for cancer treatment.

Transl Res 214:62–91

Sultan A, Gaskell H, Derry S, Andrew RA (2008) Duloxetine for painful diabetic neuropathy and

fibromyalgia pain: systematic review of randomised trials. BMC Neurol 8:29

Ta LE, Bieber AJ, Carlton SM, Loprinzi CL, Low PA, Windebank AJ (2010) Transient receptor

potential vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain 6:15

Tan T, Barry P, Reken S, Baker M (2010) Pharmacological management of neuropathic pain in

non-specialist settings: summary of NICE guidance. BMJ 340:c1079

Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin:

the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery.

Epilepsy Res 73(2):137–150

Tekade R, Maheshwari R, Sharma P, Tekade M, Chauhan A (2015) siRNA therapy, challenges and

underlying perspectives of dendrimer as delivery vector. Curr Pharm Des 21(31):4614–4636

Terashima T, Ogawa N, Nakae Y, Sato T, Katagi M, Okano J et al (2018) Gene therapy for

neuropathic pain through siRNA-IRF5 gene delivery with homing peptides to microglia. Mol

Ther Nucl Acids 11:203–215

Tesfaye S, Boulton AJM, Dickenson AH (2013) Mechanisms and management of diabetic painful

distal symmetrical polyneuropathy. Diabetes Care 36(9):2456–2465

384

R. Bhandari et al.